Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lidocaine vaginal gel - Catalent

X
Drug Profile

Lidocaine vaginal gel - Catalent

Alternative Names: 10% lidocaine gel - Juniper Pharmaceuticals; COL-1077

Latest Information Update: 20 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Columbia Laboratories
  • Developer Columbia Laboratories; Juniper Pharmaceuticals
  • Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Cell membrane permeability inhibitors; Opioid receptor agonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Pain

Highest Development Phases

  • Discontinued Dysmenorrhoea; Pain

Most Recent Events

  • 17 Aug 2016 Discontinued - Phase-II for Pain in USA (Vaginal)
  • 01 Jul 2016 Juniper Pharmaceuticals completes a phase II trial for Pain in USA (NCT02465320)
  • 16 Jun 2016 Pharmacokinetic and adverse events data from pharmacokinetic trials in healthy women volunteers released by Juniper Pharmaceuticals

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top